Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISECONTROL)

This study has been terminated.
(At time of pre-specified 2nd interim analysis)
Sponsor:
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
David Birnie, University of Ottawa Heart Institute
ClinicalTrials.gov Identifier:
NCT00800137
First received: November 26, 2008
Last updated: April 8, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
No publications provided by Ottawa Heart Institute Research Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):